RECS vs TCAF5YRECSRECSAvsBTCAFTCAFColumbia Research Enhanced Core ETF · $6.1BT. Rowe Capital Appreciation Equity ETF · $7.6BReturns · dividends in+21.4%3 years · per year$17,903 · $17,262+20.0%+12.3%5 years · per year$17,874 · […][…]Cost and income0.15%Expense ratio$15 · $31 on $10k · lower wins0.31%1.02%12-mo yield$102 · $44 on $10k
Overlap: RECS, TCAF, GDXToday1.7%most shared, RECS and TCAFRECSTCAFGDXRECS—1.7%0.7%TCAF1.7%—0.0%GDX0.7%0.0%—End-of-day Nov 10, 2026 · share held in common · outlined: the pair in versus
RECS vs TCAF5YARECSColumbia Research Enhanced Core$17,874vsTCAFBT. Rowe Capital Appreciation Equity[…]MeasureRECSTCAFFee0.15%0.31%Cost on $10k a year$15$31Yield1.02%0.44%5 years, per year+12.3%[…]3 years, per year+21.4%+20.0%Worst drop · 1Y−8.8%−10.8%Volatility · 1Y12.6%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1GDXVanEck Gold Miners ETFReadDesk0.51%0.73%−5.4%+0.8%+20.1%+44.9%+24.1%−38.9%$26.9B2ARECSColumbia Research Enhanced Core ETFReadDesk0.15%1.02%−0.6%+8.5%+11.1%+21.4%+12.3%−8.8%$6.1B3BTCAFT. Rowe Capital Appreciation Equity ETFReadDesk0.31%0.44%−0.2%+12.8%+13.7%+20.0%new−10.8%$7.6BEnd-of-day Nov 10, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1GDXVanEck Gold Miners ETFReadDesk0.51%0.73%−5.4%+0.8%+20.1%+44.9%+24.1%−38.9%$26.9B2ARECSColumbia Research Enhanced Core ETFReadDesk0.15%1.02%−0.6%+8.5%+11.1%+21.4%+12.3%−8.8%$6.1B3BTCAFT. Rowe Capital Appreciation Equity ETFReadDesk0.31%0.44%−0.2%+12.8%+13.7%+20.0%new−10.8%$7.6BEnd-of-day Nov 10, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
SCHD vs VIGYTDSchwabSCHDSA+33.8%vsBVVIGVanguard+15.1%Jan 1Nov 10+33.8%+15.1%+33.8%Year to date+15.1%2.9%Yield1.5%$123BAssets$109B2–0SCHD winsEnd-of-day Nov 10, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+6.0%vsBJMJEPIJ.P. Morgan+7.6%Jan 1Nov 10+6.0%+7.6%+6.0%Year to date+7.6%12.4%Yield7.9%$42.0BAssets$46.6B1–1levelEnd-of-day Nov 10, 2026
SPYM vs SPYYTDSPDRSPYMSA+10.9%vsBSSPYSPDR+10.8%Jan 1Nov 10+10.9%+10.8%+10.9%Year to date+10.8%1.0%Yield1.0%$183BAssets$792B1–0SPYM winsEnd-of-day Nov 10, 2026
Overlap: RECS, TCAF, GDXToday1.7%most shared, RECS and TCAFRECSTCAFGDXRECS—1.7%0.7%TCAF1.7%—0.0%GDX0.7%0.0%—End-of-day Nov 10, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$87most kept, RECSRECS$102 − $15 = $87GDX$73 − $51 = $22TCAF$44 − $31 = $13KeptFeeEnd-of-day Nov 10, 2026 · yield in dollars minus the fee